Koshinski Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-468
Closed -$243K 638
2024
Q3
$243K Buy
468
+8
+2% +$4.27K 0.02% 538
2024
Q2
$244K Buy
+460
New +$243K 0.02% 510
2023
Q4
Sell
-570
Closed -$248K 540
2023
Q3
$248K Buy
570
+31
+6% +$14.1K 0.03% 468
2023
Q2
$239K Buy
539
+58
+12% +$26.8K 0.03% 506
2023
Q1
$221K Sell
481
-3
-0.6% -$1.43K 0.02% 513
2022
Q4
$248K Buy
+484
New +$246K 0.02% 508
2022
Q3
Sell
-523
Closed -$252K 587
2022
Q2
$252K Buy
+523
New +$259K 0.03% 501

Other funds holding ELV

Koshinski Asset Management's ELV Position: Q4 2024 in Review

Koshinski Asset Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 468 shares — an estimated $243K sold.

Koshinski Asset Management first reported a position in ELV in Q2 2022 and held it in 7 quarters. The position peaked at $252K in Q2 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Koshinski Asset Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Koshinski Asset Management sold 468 Elevance Health shares in Q4 2024, an estimated $243K.
  • Koshinski Asset Management first reported a position in Elevance Health in Q2 2022 and held it in 7 quarters.
  • Koshinski Asset Management's Elevance Health position peaked at $252K in Q2 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Koshinski Asset Management's 13F filing for Q4 2024, filed 16 Jan 2025.